Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: Risk behavior, seroincidence, and willingness to participate

Journal of Infectious Diseases

Volumn 174, Issue 5, 1996, Pages 954-961

  Buchbinder, Susan P ^a   Douglas, John M ^b   McKirnan, David J ^b   Judson, Franklyn N ^b   Katz, Mitchell H ^b   MacQueen, Kathleen M ^b  

^a AIDS Office San Francisco   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; VACCINATION;

EID: 0029859582     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.5.954     Document Type: Article

References (11)

1. Hessol NA, Lifson AR, O'Malley PM, Doll SL, Jaffe HW, Rutherford GW. Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988. Am J Epidemiol 1989;130:1167-75.
2. Kingsley LA, Zhou SY, Bacellar H, et al. Temporal trends in human immunodeficiency virus type 1 seroconversion, 1984-1989. A report from the Multicenter AIDS Cohort Study (MACS). Am J Epidemiol 1991;134:331-9.
3. Centers for Disease Control. Update: acquired immunodeficiency syndrome - United States. MMWR Morb Mortal Wkly Rep 1990;39:110-9.
4. Centers for Disease Control. Update: acquired immunodeficiency syndrome - United States. MMWR Morb Mortal Wkly Rep 1994;44:65-6.
5. Heyward WL, Osmanov S, Saba J, et al. Preparation for phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence. AIDS 1994;8:1285-91.
6. Belshe RB, Graham BS, Keefer MC, et al. Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. JAMA 1994;272:475-80.
7. Vermund SH. The role of prevention research in HIV vaccine trials. Aids Res Hum Retroviruses 1994;10:5303-5.
8. Lifson AR, O'Malley PM, Hessol NA, Buchbinder SP, Cannon L, Rutherford GW. HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices. Am J Public Health 1990;80:1509-11.
9. Samuel MC, Hessol N, Shiboski S, Engel RR, Speed TP, Winkelstein W Jr. Factors associated with human immunodeficiency virus seroconversion in homosexual men in three San Francisco cohort studies, 1984-1989. J Acquir Immune Defic Syndr 1993;6:303-12.
10. D'Agostino RB, Lee ML, Belanger AI, Cupples LA, Anderson K, Kannel WB. Relation of pooled logistic regression to time-dependent cox regression analysis: the Framingham study. Stat Med 1990;9:1501-15.
11. Metzger DS, Woody GE, McLellan AT, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993;6:1049-56.